Supports the development and execution of global regulatory strategy.
Maintains relationships with relevant regulatory agencies.
Identifies risks and interpret and communicate relevant issues to project team members and senior management.
Iovance Biotherapeutics aims to be the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) therapy for people with cancer. It is committed to continuous innovation in cell therapy, with a diverse and inclusive work environment.
Own and drive the end-to-end CMC strategy across development, clinical supply, scale-up, and commercialization.
Ensure reliable preclinical, clinical and future commercial supply of safe, high-quality drug products.
Oversee global CMC regulatory strategy, ensuring alignment with FDA, EMA, and other regulatory authorities.
Faeth Therapeutics is a clinical-stage oncology company listed on Nasdaq that recently raised $200M in funding. They are a small, focused team where every person has direct impact — united by a shared commitment to care deeply, create boldly, and never stop learning.